HOME >> MEDICINE >> NEWS
Randomized Contolled Study Shows Neostigmine Is An Effective Treatment For Acute Colonic Pseudo-Obstruction

Researchers at the University of Washington School of Medicine have performed the first randomized controlled clinical trial showing that a painful and even life-threatening bowel condition called acute colonic pseudo-obstruction can be effectively treated with intravenous neostigmine.

Results of the study will be published in the July 15 issue of the New England Journal of Medicine. However, the journal is releasing the study seven weeks early on its Web site, http://www.nejm.org, to ensure that doctors who treat the condition are notified as quickly as possible. The article is entitled "Neostigmine for the Treatment of Acute Colonic Pseudo-Obstruction."

Acute colonic pseudo-obstruction occurs in some hospitalized patients following surgery or severe medical illness. The condition is caused by a loss of normal motility or spontaneous bowel action. Also called Ogilvie's syndrome, it causes a severely distended colon (large intestine).

If conservative treatments to restore normal bowel function are not successful, some patients require colonic decompression by emergency colonoscopy or surgery, to prevent ischemia (cutoff of blood supply to the bowel) or perforation of the bowel. Some 3 percent of patients with the condition suffer a perforated bowel and half of those patients die.

In this prospective, double-blind, placebo-controlled trial, Drs. Robert J. Ponec, Michael D. Sanders and Michael B. Kimmey of the Division of Gastroenterology at University of Washington Medical Center confirm earlier uncontrolled studies showing that treatment with intravenous neostigmine is effective in relieving the condition.

The UW study involved 21 patients with a wide range of medical and surgical diagnoses, who had marked abdominal distention and dilated colon and who had failed to improve after 24 hours of conservative treatment. (Conservative treatment included nothing by m
'"/>

Contact: Laurie McHale
lmchale@u.washington.edu
206-543-3620
University of Washington
25-May-1999


Page: 1 2

Related medicine news :

1. Retrospective Statistical Analysis Corroborates Early Results Of Randomized Breast Cancer Trials
2. Treatment Of Distal Ureteral Stones: ESWL Versus URS: A Prospective Randomized Study
3. Randomized Placebo-Controlled Study On The Effects Of Oral Treatment With GinkgoBiloba Extract In Patients With Erectile Dysfunction
4. Study of energy and health in Africa focuses spotlight on charcoal and forest management
5. Study shows promise in identifying kidney failure
6. Study shows patch therapy may be as effective as oral medications
7. Study shows soy is well accepted in school lunches
8. Study finds that coordinating care of chronically ill patients does not increase liability
9. Study provides new estimates of the causes of child mortality worldwide
10. Study finds factors linked to substance use disorder relapse among health care professionals
11. Study finds majority of women willing to accept cervical cancer vaccine for self and children

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/20/2019)... ... June 20, 2019 , ... The 2019 Colorado Classic® presented by ... and four top-20 UCI women’s elite teams, organizers announced today. The top-four domestic ... be coming to the race. , The standalone pro women’s road race has ...
(Date:6/19/2019)... ... ... CEO Steven C. Bilt of Smile Brands Inc. has won a Glassdoor ... , one of the world’s largest job and recruiting sites, released its annual report ... throughout North America and parts of Europe. , Smile Brands, a leading dental support ...
(Date:6/19/2019)... ... June 19, 2019 , ... The FSH ... (IRC) in Marseille, France. The conference is widely seen as the premier ... dystrophy (FSHD). Nearly 200 researchers, clinicians, industry representatives and patient advocates are attending. ...
(Date:6/19/2019)... LOS ANGELES (PRWEB) , ... June 19, 2019 , ... ... 35th European Society of Human Reproduction and Embryology (ESHRE) Annual Meeting in ... in IVF has been pre-selected for consideration for both the Basic Science Award for ...
(Date:6/18/2019)... (PRWEB) , ... June 18, 2019 , ... ... sponsors/partners have been added to its joint conference with the Houston Healthcare HR ... and panelists at the conference, HR Maximizer welcomes Staywell, Walden University, PageUp, CRC, ...
Breaking Medicine News(10 mins):
(Date:6/24/2019)... ... June 24, 2019 , ... ... to provide breathability and comfort for the electrical industry has today announced the ... safety. , The guide, titled Developing a Culture of Electrical Safety, is ...
(Date:6/20/2019)... PHILADELPHIA (PRWEB) , ... June 20, 2019 , ... ... health products, was recently named one of the Philadelphia Business Journal’s Healthiest Employers ... company’s Wellness@Work Director, Vicki Wolf, accepted the award during a ceremony at the ...
(Date:6/20/2019)... ... 2019 , ... A study released today in STEM CELLS ... to treat acute respiratory distress disorder (ARDS). This important information could point to ... Ben Antebi, Ph.D., who led the team of investigators from the U.S. Army ...
Breaking Medicine Technology:
Cached News: